{"id":"93344362-1baf-4128-afab-79991be71cdc","kind":"companies","code":"UB-C1956","name":"Xaira Therapeutics","nameBasis":"source-english","summary":"Xaira Therapeutics is a US biotechnology company","description":"Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…","country":"United States","category":null,"originalName":"Xaira Therapeutics","eventDate":null,"website":"https://www.xaira.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:26.254Z","reviewedAt":"2026-10-20T18:25:26.254Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"f5de22d426d32dd7dfd821754a8eceb1376ab79ab91c55e0eb40ef06e570eb65","companyId":null,"foundedYear":2023,"logoUrl":"https://c.ux-cdn.com/1863156737900573-5aba7b40bf5e48ca8be5896e57b70eca/uniquebase%2Flogos%2Fcompany%2FrecuoTH080KFzf%2F24da14438245f153dac7c7da2e2b5fcab0a5f90dbd04dd54bed98259382b2cf2.png","originalText":"Xaira Therapeutics是一家美国的生物科技公司\n\nXaira Therapeutics由生物技术领域最大的投资机构之一ARCH Venture Partners和Foresite Labs联合孵化。此外","sources":[],"related":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"9de734db-b019-4ea7-8bf2-1df16468f423","kind":"people","code":"UB-P694","name":"Marc Tessier-Lavigne","nameBasis":"original-brand","summary":"Founder","description":"A foreign national, as described in the source.","country":null,"category":null,"originalName":"Marc Tessier-Lavigne","eventDate":null,"website":"https://www.linkedin.com/in/marc-tessier-lavigne","sourceUpdatedAt":"2026-10-17T15:29:52.807Z","englishUpdatedAt":"2026-10-20T18:28:11.352Z","reviewedAt":"2026-10-20T18:28:11.352Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"2919b940dc7a1618b33d5f4fc275b9611f2d2d614d5d614069304cb232fbad53","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/people/marc-tessier-lavigne"},{"id":"8ccbe51f-3cbc-43a3-8cba-a289c006f0b9","kind":"institutions","code":"UB-I083","name":"Menlo Ventures","nameBasis":"original-brand","summary":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","description":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Menlo Ventures","eventDate":null,"website":"https://menlovc.com/","sourceUpdatedAt":"2026-10-20T07:00:16.229Z","englishUpdatedAt":"2026-10-20T18:26:57.038Z","reviewedAt":"2026-10-20T18:26:57.038Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9b0d63ba565ac836052a6add37841a64dc07e5ae0db435e5ea2719bb6a7c3388","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/menlo-ventures"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/parker-institute-for-cancer-immunotherapy"},{"id":"cf8826f1-5bc0-4fde-a9cd-7d5c505c13e1","kind":"institutions","code":"UB-I3371","name":"R-Squared Ventures","nameBasis":"original-brand","summary":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","description":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","country":"United States","category":null,"originalName":"R-Squared Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.163Z","englishUpdatedAt":"2026-10-20T18:27:03.652Z","reviewedAt":"2026-10-20T18:27:03.652Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"95aea1f35d6dedbdbf748c7a91ac2093e06900e4da98ec4b86f757ef07671091","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/r-squared-ventures"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"},{"id":"fc80f98c-0e16-402f-bb08-d74edefea821","kind":"institutions","code":"UB-I351","name":"SV Angel","nameBasis":"original-brand","summary":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","description":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","country":"United States","category":null,"originalName":"SV Angel","eventDate":null,"website":"https://svangel.com/","sourceUpdatedAt":"2026-10-20T01:00:11.967Z","englishUpdatedAt":"2026-10-20T18:27:14.323Z","reviewedAt":"2026-10-20T18:27:14.323Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fb5d4f34036e8c4c10deb56a2b297961a24a79f9ffc68871fdb3fa50106248ed","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sv-angel"},{"id":"53027f46-0570-4357-a46b-23f245eeadb9","kind":"institutions","code":"UB-I6117","name":"Two Sigma Ventures","nameBasis":"original-brand","summary":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","description":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","country":"United States","category":null,"originalName":"Two Sigma Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.606Z","englishUpdatedAt":"2026-10-20T18:26:56.184Z","reviewedAt":"2026-10-20T18:26:56.184Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"529bc6426f8d375154f528eb28b211cb832573c096f0a5c1ccd6ab654477d85e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/two-sigma-ventures"},{"id":"cf2d710f-a42b-4571-a28e-fef4d48826c0","kind":"products","code":"UB-D5807","name":"Xaira","nameBasis":"original-brand","summary":"Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…","description":"Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…","country":null,"category":null,"originalName":"Xaira","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T16:58:38.653Z","englishUpdatedAt":"2026-10-20T18:30:58.087Z","reviewedAt":"2026-10-20T18:30:58.087Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"9799f65a5c1b96c14bce3afb2d76927f858ea96d948654aab23482d5ab316c74","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/products/xaira"},{"id":"9f2be265-529b-4838-abab-c8800c252a73","kind":"news","code":"9f2be265-529b-4838-abab-c8800c252a73","name":"Xaira Therapeutics raises $800M Series A at $3.55B valuation","nameBasis":"translated-title","summary":"On 2025-8-15, according to PitchBook, Xaira Therapeutics completed a USD 800 million Series A financing at a USD 3.55 billion valuation","description":"","country":null,"category":null,"originalName":"Xaira Therapeutics完成8亿美元A轮融资，估值35.5亿美元","eventDate":"2025-08-15T00:00:00.000Z","website":"https://files.pitchbook.com/website/files/pdf/Q3_2025_AI_VC_Trends_Preview.pdf","sourceUpdatedAt":"2026-10-19T05:08:29.400Z","englishUpdatedAt":"2026-10-20T18:21:37.678Z","reviewedAt":"2026-10-20T18:21:37.678Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"2734d6ce0a0cadba23c8216d6bdf265a97dbe20b03134440378d64a1e301b6d2","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/news/9f2be265-529b-4838-abab-c8800c252a73"},{"id":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","kind":"news","code":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","name":"Xaira Therapeutics raises USD 1 billion in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Xaira Therapeutics完成10亿美元A轮融资","eventDate":"2024-04-23T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:58:16.219Z","englishUpdatedAt":"2026-10-15T17:19:59.284Z","reviewedAt":"2026-10-15T17:19:59.284Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5ad6b89d7cc3ff8e0f34199c32254c85f0812ae0842e0babbfa8689a3bf0349b","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/news/1a46db22-7667-456e-8c7b-4c7e0228ab2c"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"}],"finance":{"funding":{"metric":"funding","count":2,"latest":{"value":800000000,"text":"8亿美元","date":"2025-08-15T00:00:00.000Z","round":"Series A","estimate":"$800M"},"years":[2024,2025],"points":[{"year":2024,"date":"2024-04-23T00:00:00.000Z","round":"Series A","value":1000000000,"eventIds":["1a46db22-7667-456e-8c7b-4c7e0228ab2c"]},{"year":2025,"date":"2025-08-15T00:00:00.000Z","round":"Series A","value":800000000,"eventIds":["9f2be265-529b-4838-abab-c8800c252a73"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"9f2be265-529b-4838-abab-c8800c252a73","date":"2025-08-15T00:00:00.000Z","round":"Series A","amountText":"8亿美元","estimateUsd":800000000,"estimateLabel":"$800M","estimateNote":null,"investors":"ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia, Lux Capital, Lightspeed等","institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"}],"newsUrl":"https://files.pitchbook.com/website/files/pdf/Q3_2025_AI_VC_Trends_Preview.pdf","evidence":{"headline":"Xaira Therapeutics raises $800M Series A at $3.55B valuation","brief":"On 2025-8-15, according to PitchBook, Xaira Therapeutics completed a USD 800 million Series A financing at a USD 3.55 billion valuation","basis":"translated-source-brief","newsPath":"/news/9f2be265-529b-4838-abab-c8800c252a73","sourceCount":1}},{"id":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","date":"2024-04-23T00:00:00.000Z","round":"Series A","amountText":"10亿美元","estimateUsd":1000000000,"estimateLabel":"$1B","estimateNote":null,"investors":"Foresite Capital,Arch Venture Partners,Two Sigma Ventures,SV Angel,Sequoia Capital,R-Squared Ventures,Parker Institute for Cancer Immunotherapy,NEA恩颐投资,Menlo Ventures,Lux Capital,Lightspeed Venture Partners,F-Prime,拜耳","institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"8ccbe51f-3cbc-43a3-8cba-a289c006f0b9","kind":"institutions","code":"UB-I083","name":"Menlo Ventures","nameBasis":"original-brand","summary":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","description":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Menlo Ventures","eventDate":null,"website":"https://menlovc.com/","sourceUpdatedAt":"2026-10-20T07:00:16.229Z","englishUpdatedAt":"2026-10-20T18:26:57.038Z","reviewedAt":"2026-10-20T18:26:57.038Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9b0d63ba565ac836052a6add37841a64dc07e5ae0db435e5ea2719bb6a7c3388","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/menlo-ventures"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/parker-institute-for-cancer-immunotherapy"},{"id":"cf8826f1-5bc0-4fde-a9cd-7d5c505c13e1","kind":"institutions","code":"UB-I3371","name":"R-Squared Ventures","nameBasis":"original-brand","summary":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","description":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","country":"United States","category":null,"originalName":"R-Squared Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.163Z","englishUpdatedAt":"2026-10-20T18:27:03.652Z","reviewedAt":"2026-10-20T18:27:03.652Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"95aea1f35d6dedbdbf748c7a91ac2093e06900e4da98ec4b86f757ef07671091","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/r-squared-ventures"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"},{"id":"fc80f98c-0e16-402f-bb08-d74edefea821","kind":"institutions","code":"UB-I351","name":"SV Angel","nameBasis":"original-brand","summary":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","description":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","country":"United States","category":null,"originalName":"SV Angel","eventDate":null,"website":"https://svangel.com/","sourceUpdatedAt":"2026-10-20T01:00:11.967Z","englishUpdatedAt":"2026-10-20T18:27:14.323Z","reviewedAt":"2026-10-20T18:27:14.323Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fb5d4f34036e8c4c10deb56a2b297961a24a79f9ffc68871fdb3fa50106248ed","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sv-angel"},{"id":"53027f46-0570-4357-a46b-23f245eeadb9","kind":"institutions","code":"UB-I6117","name":"Two Sigma Ventures","nameBasis":"original-brand","summary":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","description":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","country":"United States","category":null,"originalName":"Two Sigma Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.606Z","englishUpdatedAt":"2026-10-20T18:26:56.184Z","reviewedAt":"2026-10-20T18:26:56.184Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"529bc6426f8d375154f528eb28b211cb832573c096f0a5c1ccd6ab654477d85e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/two-sigma-ventures"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"}],"newsUrl":null,"evidence":{"headline":"Xaira Therapeutics raises USD 1 billion in Series A financing","brief":null,"basis":null,"newsPath":"/news/1a46db22-7667-456e-8c7b-4c7e0228ab2c","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":2,"latest":{"value":3550000000,"text":"35.5亿美元(投后)","date":"2025-08-15T00:00:00.000Z","round":"Series A","estimate":"$3.55B (post-money)"},"years":[2025],"points":[{"year":2025,"date":"2025-08-15T00:00:00.000Z","round":"Series A","value":3550000000,"eventIds":["9f2be265-529b-4838-abab-c8800c252a73"]}],"linePoints":[{"year":2025,"date":"2025-08-15T00:00:00.000Z","round":"Series A","value":3550000000,"eventIds":["9f2be265-529b-4838-abab-c8800c252a73"]}],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"9f2be265-529b-4838-abab-c8800c252a73","date":"2025-08-15T00:00:00.000Z","round":"Series A","amountText":"35.5亿美元(投后)","estimateUsd":3550000000,"estimateLabel":"$3.55B (post-money)","estimateNote":null,"investors":"ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia, Lux Capital, Lightspeed等","institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"}],"newsUrl":"https://files.pitchbook.com/website/files/pdf/Q3_2025_AI_VC_Trends_Preview.pdf","evidence":{"headline":"Xaira Therapeutics raises $800M Series A at $3.55B valuation","brief":"On 2025-8-15, according to PitchBook, Xaira Therapeutics completed a USD 800 million Series A financing at a USD 3.55 billion valuation","basis":"translated-source-brief","newsPath":"/news/9f2be265-529b-4838-abab-c8800c252a73","sourceCount":1}},{"id":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","date":"2024-04-23T00:00:00.000Z","round":"Series A","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"Foresite Capital,Arch Venture Partners,Two Sigma Ventures,SV Angel,Sequoia Capital,R-Squared Ventures,Parker Institute for Cancer Immunotherapy,NEA恩颐投资,Menlo Ventures,Lux Capital,Lightspeed Venture Partners,F-Prime,拜耳","institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"8ccbe51f-3cbc-43a3-8cba-a289c006f0b9","kind":"institutions","code":"UB-I083","name":"Menlo Ventures","nameBasis":"original-brand","summary":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","description":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Menlo Ventures","eventDate":null,"website":"https://menlovc.com/","sourceUpdatedAt":"2026-10-20T07:00:16.229Z","englishUpdatedAt":"2026-10-20T18:26:57.038Z","reviewedAt":"2026-10-20T18:26:57.038Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9b0d63ba565ac836052a6add37841a64dc07e5ae0db435e5ea2719bb6a7c3388","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/menlo-ventures"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/parker-institute-for-cancer-immunotherapy"},{"id":"cf8826f1-5bc0-4fde-a9cd-7d5c505c13e1","kind":"institutions","code":"UB-I3371","name":"R-Squared Ventures","nameBasis":"original-brand","summary":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","description":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","country":"United States","category":null,"originalName":"R-Squared Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.163Z","englishUpdatedAt":"2026-10-20T18:27:03.652Z","reviewedAt":"2026-10-20T18:27:03.652Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"95aea1f35d6dedbdbf748c7a91ac2093e06900e4da98ec4b86f757ef07671091","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/r-squared-ventures"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"},{"id":"fc80f98c-0e16-402f-bb08-d74edefea821","kind":"institutions","code":"UB-I351","name":"SV Angel","nameBasis":"original-brand","summary":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","description":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","country":"United States","category":null,"originalName":"SV Angel","eventDate":null,"website":"https://svangel.com/","sourceUpdatedAt":"2026-10-20T01:00:11.967Z","englishUpdatedAt":"2026-10-20T18:27:14.323Z","reviewedAt":"2026-10-20T18:27:14.323Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fb5d4f34036e8c4c10deb56a2b297961a24a79f9ffc68871fdb3fa50106248ed","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sv-angel"},{"id":"53027f46-0570-4357-a46b-23f245eeadb9","kind":"institutions","code":"UB-I6117","name":"Two Sigma Ventures","nameBasis":"original-brand","summary":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","description":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","country":"United States","category":null,"originalName":"Two Sigma Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.606Z","englishUpdatedAt":"2026-10-20T18:26:56.184Z","reviewedAt":"2026-10-20T18:26:56.184Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"529bc6426f8d375154f528eb28b211cb832573c096f0a5c1ccd6ab654477d85e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/two-sigma-ventures"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"}],"newsUrl":null,"evidence":{"headline":"Xaira Therapeutics raises USD 1 billion in Series A financing","brief":null,"basis":null,"newsPath":"/news/1a46db22-7667-456e-8c7b-4c7e0228ab2c","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"9f2be265-529b-4838-abab-c8800c252a73","kind":"funding","eventDate":"2025-08-15T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"8亿美元","valuationText":"35.5亿美元(投后)","revenueText":"","cumulativeFundingText":"","amountEstimateUsd":800000000,"valuationEstimateUsd":3550000000,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia, Lux Capital, Lightspeed等","newsUrl":"https://files.pitchbook.com/website/files/pdf/Q3_2025_AI_VC_Trends_Preview.pdf","newsTypes":["融资","估值"],"institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"}],"roundName":"Series A","amountLabel":"$800M","valuationLabel":"$3.55B (post-money)","revenueLabel":null,"cumulativeFundingLabel":null},{"id":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","kind":"funding","eventDate":"2024-04-23T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"10亿美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":1000000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"Foresite Capital,Arch Venture Partners,Two Sigma Ventures,SV Angel,Sequoia Capital,R-Squared Ventures,Parker Institute for Cancer Immunotherapy,NEA恩颐投资,Menlo Ventures,Lux Capital,Lightspeed Venture Partners,F-Prime,拜耳","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"8ccbe51f-3cbc-43a3-8cba-a289c006f0b9","kind":"institutions","code":"UB-I083","name":"Menlo Ventures","nameBasis":"original-brand","summary":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","description":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Menlo Ventures","eventDate":null,"website":"https://menlovc.com/","sourceUpdatedAt":"2026-10-20T07:00:16.229Z","englishUpdatedAt":"2026-10-20T18:26:57.038Z","reviewedAt":"2026-10-20T18:26:57.038Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9b0d63ba565ac836052a6add37841a64dc07e5ae0db435e5ea2719bb6a7c3388","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/menlo-ventures"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/parker-institute-for-cancer-immunotherapy"},{"id":"cf8826f1-5bc0-4fde-a9cd-7d5c505c13e1","kind":"institutions","code":"UB-I3371","name":"R-Squared Ventures","nameBasis":"original-brand","summary":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","description":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","country":"United States","category":null,"originalName":"R-Squared Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.163Z","englishUpdatedAt":"2026-10-20T18:27:03.652Z","reviewedAt":"2026-10-20T18:27:03.652Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"95aea1f35d6dedbdbf748c7a91ac2093e06900e4da98ec4b86f757ef07671091","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/r-squared-ventures"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"},{"id":"fc80f98c-0e16-402f-bb08-d74edefea821","kind":"institutions","code":"UB-I351","name":"SV Angel","nameBasis":"original-brand","summary":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","description":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","country":"United States","category":null,"originalName":"SV Angel","eventDate":null,"website":"https://svangel.com/","sourceUpdatedAt":"2026-10-20T01:00:11.967Z","englishUpdatedAt":"2026-10-20T18:27:14.323Z","reviewedAt":"2026-10-20T18:27:14.323Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fb5d4f34036e8c4c10deb56a2b297961a24a79f9ffc68871fdb3fa50106248ed","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sv-angel"},{"id":"53027f46-0570-4357-a46b-23f245eeadb9","kind":"institutions","code":"UB-I6117","name":"Two Sigma Ventures","nameBasis":"original-brand","summary":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","description":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","country":"United States","category":null,"originalName":"Two Sigma Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.606Z","englishUpdatedAt":"2026-10-20T18:26:56.184Z","reviewedAt":"2026-10-20T18:26:56.184Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"529bc6426f8d375154f528eb28b211cb832573c096f0a5c1ccd6ab654477d85e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/two-sigma-ventures"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"}],"roundName":"Series A","amountLabel":"$1B","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"9de734db-b019-4ea7-8bf2-1df16468f423","kind":"people","code":"UB-P694","name":"Marc Tessier-Lavigne","nameBasis":"original-brand","summary":"Founder","description":"A foreign national, as described in the source.","country":null,"category":null,"originalName":"Marc Tessier-Lavigne","eventDate":null,"website":"https://www.linkedin.com/in/marc-tessier-lavigne","sourceUpdatedAt":"2026-10-17T15:29:52.807Z","englishUpdatedAt":"2026-10-20T18:28:11.352Z","reviewedAt":"2026-10-20T18:28:11.352Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"2919b940dc7a1618b33d5f4fc275b9611f2d2d614d5d614069304cb232fbad53","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/people/marc-tessier-lavigne"}],"productsRelated":[{"id":"cf2d710f-a42b-4571-a28e-fef4d48826c0","kind":"products","code":"UB-D5807","name":"Xaira","nameBasis":"original-brand","summary":"Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…","description":"Xaira Therapeutics was jointly incubated by ARCH Venture Partners, one of the largest biotechnology investors, and Foresite Labs. In addition…","country":null,"category":null,"originalName":"Xaira","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T16:58:38.653Z","englishUpdatedAt":"2026-10-20T18:30:58.087Z","reviewedAt":"2026-10-20T18:30:58.087Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"9799f65a5c1b96c14bce3afb2d76927f858ea96d948654aab23482d5ab316c74","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/products/xaira"}],"investors":[{"id":"44c209df-3092-4004-a255-38728839015a","kind":"institutions","code":"UB-I286","name":"ARCH Venture Partners","nameBasis":"original-brand","summary":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","description":"A prominent US hard technology and biotechnology venture capital firm focused on early-stage deep technology and life sciences investments.","country":"United States","category":null,"originalName":"ARCH Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.707Z","englishUpdatedAt":"2026-10-20T18:26:50.014Z","reviewedAt":"2026-10-20T18:26:50.014Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1fb2cb6bf3923d0c17e153c81bdb363e4f01e13259601a1234b35c6f3d16a20d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch-venture-partners"},{"id":"256eeeaf-f1b6-4c22-866e-921387606263","kind":"institutions","code":"UB-I288","name":"F-Prime","nameBasis":"original-brand","summary":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","description":"F-Prime Capital, a US venture capital firm focused on early-stage healthcare and technology investments.","country":"United States","category":null,"originalName":"F-Prime","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.504Z","englishUpdatedAt":"2026-10-20T18:26:49.575Z","reviewedAt":"2026-10-20T18:26:49.575Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"84ce1dfb6f9a078a25b1b398e0c89a922abab3a70718f37f0f08e880755968c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/f-prime"},{"id":"25a1784b-31d2-4ee5-98d1-d076ea082d1a","kind":"institutions","code":"UB-I287","name":"Foresite Capital","nameBasis":"original-brand","summary":"A US venture capital firm focused on healthcare and biotechnology investments.","description":"A US venture capital firm focused on healthcare and biotechnology investments.","country":"United States","category":null,"originalName":"Foresite Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:14.844Z","englishUpdatedAt":"2026-10-20T18:26:49.580Z","reviewedAt":"2026-10-20T18:26:49.580Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"ddc6028723b6d8e0b915c7a8f8bf5c41c3caccc419876a80077e3bd3e405abdb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/foresite-capital"},{"id":"f021e728-d47d-42a3-b9cf-92267d04a380","kind":"institutions","code":"UB-I071","name":"Lightspeed Venture Partners","nameBasis":"original-brand","summary":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","description":"A globally prominent venture capital firm covering early- and growth-stage technology investments in the US, China, Israel, and other markets.","country":"United States","category":null,"originalName":"Lightspeed Venture Partners","eventDate":null,"website":"https://lsvp.com/","sourceUpdatedAt":"2026-10-20T17:00:11.953Z","englishUpdatedAt":"2026-10-20T18:27:14.141Z","reviewedAt":"2026-10-20T18:27:14.141Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8e6bc3e57efba18a82759c2037ad0df55187d5e561fda8e51a496b46a32345c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lightspeed-venture-partners"},{"id":"56a67244-77f5-4b2e-a98e-368df714aa7b","kind":"institutions","code":"UB-I114","name":"Lux Capital","nameBasis":"original-brand","summary":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","description":"A US hard technology and frontier science venture capital firm focused on early-stage deep technology.","country":"United States","category":null,"originalName":"Lux Capital","eventDate":null,"website":"https://luxcapital.com/","sourceUpdatedAt":"2026-10-18T22:00:12.357Z","englishUpdatedAt":"2026-10-20T18:26:56.246Z","reviewedAt":"2026-10-20T18:26:56.246Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c9489b164b34f0fa1f2f2267f72124648704f03fecba6988dc3e46cc1f0a14d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/lux-capital"},{"id":"8ccbe51f-3cbc-43a3-8cba-a289c006f0b9","kind":"institutions","code":"UB-I083","name":"Menlo Ventures","nameBasis":"original-brand","summary":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","description":"A long-established Silicon Valley venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Menlo Ventures","eventDate":null,"website":"https://menlovc.com/","sourceUpdatedAt":"2026-10-20T07:00:16.229Z","englishUpdatedAt":"2026-10-20T18:26:57.038Z","reviewedAt":"2026-10-20T18:26:57.038Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9b0d63ba565ac836052a6add37841a64dc07e5ae0db435e5ea2719bb6a7c3388","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/menlo-ventures"},{"id":"42ad885e-f9f5-4cf8-841b-6fdf900497e2","kind":"institutions","code":"UB-I133","name":"NEA","nameBasis":"original-brand","summary":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","description":"New Enterprise Associates, a globally prominent venture capital firm covering technology and healthcare.","country":"United States","category":null,"originalName":"NEA","eventDate":null,"website":"https://nea.com/","sourceUpdatedAt":"2026-10-18T22:00:14.020Z","englishUpdatedAt":"2026-10-20T18:26:49.988Z","reviewedAt":"2026-10-20T18:26:49.988Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"09c4d17d0534de3f930d40a290215c331015890ca9feab9e7af4f46c64cb1a4a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nea"},{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/parker-institute-for-cancer-immunotherapy"},{"id":"cf8826f1-5bc0-4fde-a9cd-7d5c505c13e1","kind":"institutions","code":"UB-I3371","name":"R-Squared Ventures","nameBasis":"original-brand","summary":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","description":"R-Squared Ventures is a venture capital firm based in the United States, investing in seed- to growth-stage technology ventures.","country":"United States","category":null,"originalName":"R-Squared Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.163Z","englishUpdatedAt":"2026-10-20T18:27:03.652Z","reviewedAt":"2026-10-20T18:27:03.652Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"95aea1f35d6dedbdbf748c7a91ac2093e06900e4da98ec4b86f757ef07671091","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/r-squared-ventures"},{"id":"8a7869c8-a5a6-4719-b092-296c4c03bba1","kind":"institutions","code":"UB-I091","name":"Sequoia Capital","nameBasis":"original-brand","summary":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","description":"Sequoia Capital in the US, one of the world's most influential venture capital firms, covering early- to growth-stage technology enterprises.","country":"United States","category":null,"originalName":"Sequoia Capital","eventDate":null,"website":"https://sequoiacap.com/","sourceUpdatedAt":"2026-10-20T17:00:11.988Z","englishUpdatedAt":"2026-10-20T18:26:56.975Z","reviewedAt":"2026-10-20T18:26:56.975Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"135d542c6d62aab6adb11f0a5afebeef89ad92abfdab9dd759a1f1c2dd033be6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sequoia-capital"},{"id":"fc80f98c-0e16-402f-bb08-d74edefea821","kind":"institutions","code":"UB-I351","name":"SV Angel","nameBasis":"original-brand","summary":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","description":"A well-known US angel investment firm focused on early-stage Silicon Valley technology startups.","country":"United States","category":null,"originalName":"SV Angel","eventDate":null,"website":"https://svangel.com/","sourceUpdatedAt":"2026-10-20T01:00:11.967Z","englishUpdatedAt":"2026-10-20T18:27:14.323Z","reviewedAt":"2026-10-20T18:27:14.323Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fb5d4f34036e8c4c10deb56a2b297961a24a79f9ffc68871fdb3fa50106248ed","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sv-angel"},{"id":"53027f46-0570-4357-a46b-23f245eeadb9","kind":"institutions","code":"UB-I6117","name":"Two Sigma Ventures","nameBasis":"original-brand","summary":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","description":"Two Sigma Ventures is a venture capital firm based in the United States, investing in seed-, startup- and growth-stage technology ventures.","country":"United States","category":null,"originalName":"Two Sigma Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.606Z","englishUpdatedAt":"2026-10-20T18:26:56.184Z","reviewedAt":"2026-10-20T18:26:56.184Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"529bc6426f8d375154f528eb28b211cb832573c096f0a5c1ccd6ab654477d85e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/two-sigma-ventures"},{"id":"ffe4868b-3fad-4891-9916-e5dd7e07e274","kind":"institutions","code":"UB-I5336","name":"拜耳","nameBasis":"transliterated","summary":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","description":"Baier is a Chinese venture capital firm, specializing in equity investment in early- to growth-stage technology startups.","country":null,"category":null,"originalName":"拜耳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:24.319Z","englishUpdatedAt":"2026-10-15T18:26:25.264Z","reviewedAt":"2026-10-15T18:26:25.264Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5808cdf9b33bb071061d0b8562338a902031ad3ceedcff7d6f67a6b6f44de565","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Baier","path":"/institutions/baier"}],"path":"/companies/xaira-therapeutics","structured":{"city":"San Francisco","country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Xaira Therapeutics is a company in the Industry apps sector headquartered in San Francisco, United States, founded in 2023.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/xaira-therapeutics"}